BB Biotech AG
Status: Publicly traded
Direct answer
BB Biotech AG is publicly traded on SIX under the ticker BION.SW.
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is...
Can you invest in BB Biotech AG?
Yes. BB Biotech AG trades publicly on SIX as BION.SW.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BB Biotech AG
Detailed equity research is provided by MarketSnap.